GKFF
QTTB icon

George Kaiser Family Foundation’s Q32 Bio QTTB Stock Holding History

George Kaiser Family Foundation’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,029
Closed -$186K – 21
2023
Q4 		$186K Buy
17,029
+14,845
+680% +$217K 0.04% 18
2023
Q3 		$46K Buy
+2,184
New +$44.5K 0.01% 41

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

George Kaiser Family Foundation's QTTB Position: Q1 2024 in Review

George Kaiser Family Foundation sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 17,029 shares — an estimated $186K sold.

George Kaiser Family Foundation first reported a position in QTTB in Q3 2023 and held it in 2 quarters. The position peaked at $186K in Q4 2023. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • George Kaiser Family Foundation reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • George Kaiser Family Foundation sold 17,029 Q32 Bio shares in Q1 2024, an estimated $186K.
  • George Kaiser Family Foundation first reported a position in Q32 Bio in Q3 2023 and held it in 2 quarters.
  • George Kaiser Family Foundation's Q32 Bio position peaked at $186K in Q4 2023.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on George Kaiser Family Foundation's 13F filing for Q1 2024, filed 6 May 2024.